EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Cognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study

Aikaterini Theodorou iD, Athanasia Athanasaki, Konstantinos Melanis iD, Ioanna Pachi iD, Angeliki Sterpi iD, Eleftheria Koropouli, Eleni Bakola iD, Maria Chondrogianni, Maria-Ioanna Stefanou, Efthimios Vasilopoulos iD, Anastasios Kouzoupis, Georgios P Paraskevas iD und 2 weitere

Journal of Clinical Medicine · 06.12.2024 · 13 (23) · 7427

DOI: 10.3390/jcm13237427 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.12.2024. Verfasst von Aikaterini Theodorou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Gree…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Cognitive impairment represents a core and prodromal clinical feature of cerebral amyloid angiopathy (CAA). We sought to assess specific cognitive domains which are mainly affected among patients with CAA and to investigate probable associations with neuroimaging markers and Cerebrospinal Fluid (CSF) biomarkers.

Methods

Thirty-five patients fulfilling the Boston Criteria v1.5 or v2.0 for the diagnosis of probable/possible CAA were enrolled in this prospective cohort study. Brain Magnetic Resonance Imaging and CSF biomarker data were collected. Every eligible participant underwent a comprehensive neurocognitive assessment. Spearman’s rank correlation tests were used to identify possible relationships between the Addenbrooke’s Cognitive Examination—Revised (ACE-R) sub-scores and other neurocognitive test scores and the CSF biomarker and neuroimaging parameters among CAA patients. Moreover, linear regression analyses were used to investigate the effects of CSF biomarkers on the ACE-R total score and Mini-Mental State Examination (MMSE) score, based on the outcomes of univariate analyses.

Results

Cognitive impairment was detected in 80% of patients, and 60% had a coexistent Alzheimer’s disease (AD) pathology based on CSF biomarker profiles. Notable correlations were identified between increased levels of total tau (t-tau) and phosphorylated tau (p-tau) and diminished performance in terms of overall cognitive function, especially memory. In contrast, neuroimaging indicators, including lobar cerebral microbleeds and superficial siderosis, had no significant associations with cognitive scores. Among the CAA patients, those without AD had superior neurocognitive test performance, with significant differences observed in their ACE-R total scores and memory sub-scores.

Conclusions

The significance of tauopathy in cognitive impairment associated with CAA may be greater than previously imagined, underscoring the necessity for additional exploration of the non-hemorrhagic facets of the disease and new neuroimaging markers.

Schlagwörter

Stichwörter der Autor:innen

assessmentcerebral amyloid angiopathycognitive impairmentneurocognitive testingneuroimaging markers

Autor:innen und Institutionen

  • Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Department of Neurology & Stroke, Eberhard-Karls University of Tübingen, 72076 Tübingen, Germany.
  • Hertie Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, 72076 Tübingen, Germany.
  • First Department of Psychiatry, "Aiginition" Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Aikaterini Theodorou, Konstantinos Melanis, Ioanna Pachi, Angeliki Sterpi, Eleni Bakola, Efthimios Vasilopoulos, Georgios P Paraskevas, Georgios Tsivgoulis, Elias Tzavellas

Zitieren

APA

Theodorou, A., Athanasaki, A., Melanis, K., Pachi, I., Sterpi, A., Koropouli, E., Bakola, E., Chondrogianni, M., Stefanou, M. I., Vasilopoulos, E., Kouzoupis, A., Paraskevas, G. P., Tsivgoulis, G., & Tzavellas, E. (2024). Cognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study. Journal of Clinical Medicine, 13(23), 7427. https://doi.org/10.3390/jcm13237427

Vancouver

Theodorou A, Athanasaki A, Melanis K, Pachi I, Sterpi A, Koropouli E, et al. Cognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study. Journal of Clinical Medicine. 2024;13(23):7427. doi:10.3390/jcm13237427

BibTeX
@article{Theodorou2024,
  author = {Theodorou, Aikaterini and Athanasaki, Athanasia and Melanis, Konstantinos and Pachi, Ioanna and Sterpi, Angeliki and Koropouli, Eleftheria and Bakola, Eleni and Chondrogianni, Maria and Stefanou, Maria-Ioanna and Vasilopoulos, Efthimios and Kouzoupis, Anastasios and Paraskevas, Georgios P and Tsivgoulis, Georgios and Tzavellas, Elias},
  title = {Cognitive Impairment in Cerebral Amyloid Angiopathy: A Single-Center Prospective Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {7427},
  doi = {10.3390/jcm13237427}
}
Kostenlos starten →